(Q40510758)

English

The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection

scientific article published on September 2004

Statements

The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection (English)
Beverley J Smith
Charles T Heise
Prakash D Nayee
Deborah A Sanders
Graeme Alexander
Stephen D Gillies
Matthew P Baker

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit